Work

Real-world outcomes of PK/PD-guided individualized emicizumab dose reduction in Chinese pediatric patients with hemophilia A: A prospective observational study

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-4840

Authors: Qianqian Mao, Zhengping Li, Zhenping Chen, Runhui Wu

Institution: Beijing Children’s Hospital

Language: English

Topic: Hemophilia Treatment and Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417013585

Cites:

Cited by:

Related to: